tirzepatide and osteoarthritis The Cost-Effectiveness of Semaglutide for Patients With Knee and Obesity tirzepatide joint pain - Diabetes
Description
Despite the difference in milligram amounts, each drug is calibrated to its own potency scale
The concern is valid, given that these medications directly affect pancreatic function
Tirzepatide was approved by the FDA for A1c lowering in Type 2 Diabetes in May 2022 Although it has not yet been approved for obesity, tirzepatide demonstrated significant weight reduction when analyzed as the secondary outcome in the SURPASS trials and as the primary outcome in the SURMOUNT I trial
If your insurance doesnt cover the medication, it can be costly (medication + membership)
